A pan-cancer analysis of HER2 index revealed transcriptional pattern for precise selection of HER2-targeted therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A pan-cancer analysis of HER2 index revealed transcriptional pattern for precise selection of HER2-targeted therapy

Published:2020-12 Issue: Volume:62 Page:103074
ISSN:2352-3964
Container-title:eBioMedicine
language:en
Short-container-title:eBioMedicine

Author:

Li Ziteng,Chen Siyuan,Feng Wanjing,Luo Yixiao,Lai Hongyan,Li Qin,Xiu Bingqiu,Li Yuchen,Li Yan,Huang Shenglin,Zhu Xiaodong

Funder

National Key Research and Development Program of China

Shanghai Shenkang Hospital Development Center

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference60 articles.

1. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial;Bang;Lancet (Lond, Engl),2010

2. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2;Slamon;N Engl J Med,2001

3. HER2-targeted therapies - a role beyond breast cancer;Oh;Nat Rev Clin Oncol,2019

4. Untangling the ErbB signalling network;Yarden;Nat Rev Mol Cell Biol,2001

5. Human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update;Wolff;J Clin Oncol,2018

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HER-2 directed therapies across gastrointestinal tract cancers – A new frontier;Cancer Treatment Reviews;2024-09

2. IKZF3 amplification predicts worse prognosis especially in intestinal-type gastric cancer;Journal of Cancer Research and Clinical Oncology;2024-07-25

3. IKZF3 amplification predicts worse prognosis especially in intestinal-type gastric cancer;2024-05-30

4. Molecular understanding and clinical outcomes of CAR T cell therapy in the treatment of urological tumors;Cell Death & Disease;2024-05-24

5. NIFK, a Potential Prognostic and Immunological Biomarker in Pan-- Cancer Analysis, Significantly Regulates Proliferation and Metastasis of Colorectal Cancer;Recent Patents on Anti-Cancer Drug Discovery;2024-04-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3